Olink Holding Ab Publ (OLK) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket
 


Olink Holding Ab publ   (NASDAQ: OLK)


Olink Holding Ab Publ's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Olink Holding Ab Publ's ROI in the fourth quarter of 2023?
Olink Holding Ab Publ recorded a cumulative net loss of $-32 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -18.62%.

Within the Healthcare sector 655 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 4225.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM 28.41 % -4.08 % -48.13 % -65.04 % -73.99 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 547 44 44 44 440
Return On Investment (TTM) -18.62 % -8.98 % -9.21 % -9.46 % -9.72 %
OLK's Overall Ranking # 4225 # 0 # 0 # 0 # 4644
Seq. Investment Change TTM 18.62 % 2.61 % 2.68 % 2.75 % -11.39 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -32 -13 -13 -13 -13




Return On Investment OLK's Ranking
Within: No.
Industry # 21
Sector # 656
Overall # 4225

Return On Investment Statistics
High Average Low
-7.54 %
-40.93 %
-71.71 %
(Dec 31 2021)   (Dec 31 2023)



  News about Olink Holding Ab publ Return on Investment ROI

Olink Launches Global Network of Certified Service Providers to Revolutionize Protein Biomarker Discovery, Despite Financial Challenges

July 3, 2024


Olink Holding Ab Publ, a pioneering company in the field of protein biomarker discovery, has recently unveiled a global network of certified service providers. This strategic move aims to rapidly advance the discovery and analysis of protein biomarkers, empowering researchers and healthcare professionals worldwide.
The inaugural network of Olink Certified Service Providers includes leading contract research organizations (CROs) and service labs spread across the globe. By expanding its reach and collaborating with established entities in the field, Olink aims to harness the power of collective expertise, infrastructure, and resources. This move will result in increased accessibility to Olink s innovative technology and superior products, ultimately driving breakthrough discoveries in the field of protein biomarker research.






Financial Statements
Olink Holding Ab Publ's IV. Quarter Investments $ 547 Millions OLK's Balance sheet
Olink Holding Ab Publ's IV. Quarter Income $ -32 Millions Quarterly OLK's Income Statement
OLK's Income by Division See OLK's Income by Division


OLK Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021


Total Investments in Millions 547 440 508 0 0
Y / Y Investment Growth 24.21 % -13.38 % - - -
Net Income in Millions -32 -13 -38 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -5.78 % -2.92 % -7.54 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OLK's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OLK's Competitors
Subscribers only: Roi for Olink Holding Ab Publ's Suppliers
Subscribers only: Return On Investment for OLK's Customers

Other Ratios
OLK's Roa OLK's Inventory Turnover Ratio OLK's Growth Rates OLK's Dividend Statistics
OLK's Profitability Ratios OLK's Asset Turnover Ratio OLK's Dividend Growth
OLK's Roe OLK's Valuation Ratios OLK's Financial Strength Ratios OLK's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.